Medicenna Therapeutics Corp. (MDNA) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 55.12M |
| Enterprise Value | 21.52M |
| P/E Ratio | -1.86 |
| PEG Ratio | 0.06 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 21.23 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | -1.14 |
Fiscal Year
| Fiscal Year | March 31, 2023 |
| Most Recent Quarter | September 30, 2023 |
Profitability
| Profit Margin | 0 |
| Operating Margin | 0 |
AD
Management Effectiveness
| Return On Assets | -2.25 |
| Return On Equity | -3.6 |
Income Statement
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | 0 |
| EBITDA | -21.64M |
| Net Income | 1.55M |
| Diluted EPS | 0.02 |
Balance Sheet
| Total Cash | 25.69M |
| Total Cash/Share | 0.07 |
| Total Debt | 0 |
| Total Debt/Equity | 0.06 |
| Current Ratio | 1.25 |
| Book Value Per Share | 0.02 |
Price History
| 52-Week Change | 0 |
| 52-Week High | 0.2 |
| 52-Week Low | 0.15 |
| Moving Average 50 Days | 0.16 |
| Moving Average 200 Days | 0.16 |
Statistics
| Average Volume | 1.26M |
| Shares Outstanding | 0 |
| % Held by Institutions | 0.25 |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
AD
